Temozolomide in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT00004113 · COMPLETED

Trial details

NCT number: NCT00004113
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1999-06-01
Primary completion: 2001-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.